Schistosoma mansoni infects about 200 million people in many tropical and sub-tropical areas of the world causing serious health hazards. The S. mansoni G binding factor protein is a potential drug target for treating the parasite.
| Institute |
|---|
| University of Illinois Chicago |
| Cat. #: | 156383 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Immunology;Microbiology |
| Application: | WB ; FACS ; ELISA |
| Target: | G-Binding Factor |
| Reactivity: | Schistosoma mansoni |
| Host: | Rabbit |
| Class: | Polyclonal |
| Alternate name: | GBF |
|---|---|
| Product description: | Schistosoma mansoni infects about 200 million people in many tropical and sub-tropical areas of the world causing serious health hazards. The S. mansoni G binding factor protein is a potential drug target for treating the parasite. |
| Conjugation: | Unconjugated |
| Immunogen: | G Binding Factor (GBF) |
| Target background: | Schistosoma mansoni infects about 200 million people in many tropical and sub-tropical areas of the world causing serious health hazards. The S. mansoni G binding factor protein is a potential drug target for treating the parasite. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Rao et al. 2002. J Biol Chem. 277(34):31207-13. PMID: 12050167. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.